Mitsui Chemicals Agrees to ¥1.84 Trillion JSR Acquisition, Raising Debt and Dilution Risks

What exactly did Mitsui Chemicals agree to acquire?

Mitsui Chemicals signed an agreement to acquire JSR from funds managed by JIC Capital, with Development Bank of Japan investing ¥200 billion through shares intended to become nonvoting preferred stock, leaving Mitsui with 100% of JSR's voting rights after completion.

Orbitrum Investor Impact

Why does acquiring JSR matter for Mitsui Chemicals?

JSR's advanced semiconductor photoresists and customer relationships would complement Mitsui's existing chip materials portfolio, with the company targeting approximately ¥40 billion in additional annual profit from growth and cost synergies by fiscal 2035, although these benefits remain projections.

How will Mitsui Chemicals finance the ¥1.84 trillion acquisition?

The stated transaction value comprises ¥1.3921 trillion in equity value and ¥447.9 billion in interest bearing debt and other items, while the financing plan includes a ¥1.64 trillion bridge loan and ¥200 billion from Development Bank of Japan. Mitsui subsequently intends to refinance the bridge loan through debt, equity and mezzanine financing.

Could the JSR acquisition dilute Mitsui Chemicals shareholders?

Yes, Mitsui Chemicals registered a potential common share issuance of up to ¥150 billion, which could dilute existing shareholders if implemented, while its projected net debt to EBITDA ratio would temporarily exceed four times after completion. Reuters reported that Mitsui shares fell 8.5% on November 9 amid concerns about acquisition financing and potential synergies.

Is JSR already generating enough profit to support the acquisition?

JSR reported ¥440.718 billion in revenue and ¥40.528 billion in consolidated operating profit for the fiscal year ended March 2026, but these historical earnings do not establish whether future profits and synergies will cover Mitsui's increased financing costs.

When will Mitsui Chemicals complete the JSR acquisition?

Mitsui targets completion in the second half of its fiscal year ending March 2028, subject to competition approvals, foreign investment reviews and other closing conditions. Investors must also monitor the planned refinancing, possible share issuance and whether the projected semiconductor materials synergies materialize.